603127 Joinn Laboratories (China) Co.,Ltd.
Closed 04-18 15:00:00
15.52
+0.07
+0.45%
High
15.98
Low
15.34
Vol
18.01M
Open
15.46
D1 Closing
15.45
Amplitude
4.14%
Mkt Cap
11.62B
Tradable Cap
9.78B
Total Shares
749.00M
T/O
281.00M
T/O Rate
2.86%
Tradable Shares
630.00M
P/B
1.44
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
BRIEF-Joinn Laboratories China Says Member Of Group Subscribed For Securities Financial Products
Reuters · 04-14
BRIEF-Joinn Laboratories China Says Member Of Group Subscribed For Securities Financial Products
Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024
MT Newswires Live · 01-27
Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024
BRIEF-Joinn Laboratories China Sees Operating Revenue In 2024
Reuters · 01-24
BRIEF-Joinn Laboratories China Sees Operating Revenue In 2024
Joinn Laboratories China Sees Net Profit Attributable to Range From RMB58.7 Mln to RMB88 Mln for FY
THOMSON REUTERS · 01-24
Joinn Laboratories China Sees Net Profit Attributable to Range From RMB58.7 Mln to RMB88 Mln for FY
Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson
MT Newswires Live · 2024-12-23
Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson
Joinn Laboratories China Co Ltd - Resolved to Nominate Gu Jingliang as an Executive Director
THOMSON REUTERS · 2024-12-20
Joinn Laboratories China Co Ltd - Resolved to Nominate Gu Jingliang as an Executive Director
Joinn Laboratories' Q3 Profit Slides 58%
MT Newswires Live · 2024-11-01
Joinn Laboratories' Q3 Profit Slides 58%
Joinn Laboratories China - Qtrly REV RMB485.8 Mln
THOMSON REUTERS · 2024-10-30
Joinn Laboratories China - Qtrly REV RMB485.8 Mln
Joinn Laboratories China - Resolved to Nominate Xi Luo as Executive Director
THOMSON REUTERS · 2024-10-30
Joinn Laboratories China - Resolved to Nominate Xi Luo as Executive Director
Load more
Introduction
Company Name.
北京昭衍新药研究中心股份有限公司
Industry:
研究和试验发展
Listing Date:
2017-08-25
Main Business:
北京昭衍新药研究中心股份有限公司的主营业务是从事以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。
Issue price:
12.51
Invest in Global Markets with Tiger Brokers!
Open App
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"Joinn Laboratories (China) Co.,Ltd.","latestPrice":15.52,"timestamp":1744959600000,"preClose":15.45,"halted":0,"volume":18010113,"delay":0,"changeRate":0.0045,"floatShares":630000000,"shares":749000000,"eps":-0.3321,"marketStatus":"Closed","change":0.07,"latestTime":"04-18 15:00:00","open":15.46,"high":15.98,"low":15.34,"amount":281000000,"amplitude":0.0414,"askPrice":15.53,"askSize":667,"bidPrice":15.52,"bidSize":40,"shortable":0,"etf":0,"ttmEps":-0.3321,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745199000000},"marketStatusCode":5,"adr":0,"adjPreClose":15.45,"symbolType":"stock","openAndCloseTimeList":[[1744939800000,1744947000000],[1744952400000,1744959600000]],"highLimit":17,"lowLimit":13.91,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749477334,"isCdr":false,"pbRate":1.44,"roa":"--","roe":"0.91%","epsLYR":0.1,"committee":0.12983,"marketValue":11632000000,"turnoverRate":0.0286,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-04-22.","hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"JOINN","latestPrice":9.79,"timestamp":1744877289036,"preClose":9.77,"halted":0,"volume":2754504,"delay":0,"premium":"-40.67"},"floatMarketCap":9785000000},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2527948194","title":"BRIEF-Joinn Laboratories China Says Member Of Group Subscribed For Securities Financial Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2527948194","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527948194?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 23:34","pubTimestamp":1744644878,"startTime":"0","endTime":"0","summary":"BRIEF-Joinn Laboratories China Says Member Of Group Subscribed For Securities Financial ProductsApril 14 - Joinn Laboratories China Co Ltd 603127.SS:MEMBER OF GROUP SUBSCRIBED FOR CITIC SECURITIES FINANCIAL PRODUCTS OF OUTSTANDING INVESTMENT AMOUNT RMB400 MILLIONFurther company coverage: 603127.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS20G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603127","BK0216"],"gpt_icon":0},{"id":"2506376683","title":"Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2506376683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506376683?lang=en_us&edition=full_marsco","pubTime":"2025-01-27 20:07","pubTimestamp":1737979647,"startTime":"0","endTime":"0","summary":"Joinn Laboratories expects a net profit attributable to shareholders of around 58.7 million yuan and 88.0 million yuan for 2024, representing a between 77.8% to 85.2% year-over-year decline.The drug developer attributed the forecast to lower gross profit margins and the decrease in the market price of biological assets held by the company, a Friday Hong Kong bourse filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0216","603127","BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2505237864","title":"BRIEF-Joinn Laboratories China Sees Operating Revenue In 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2505237864","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505237864?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 23:31","pubTimestamp":1737732719,"startTime":"0","endTime":"0","summary":"BRIEF-Joinn Laboratories China Sees Operating Revenue In 2024Jan 24 - Joinn Laboratories China Co Ltd 603127.SS:SEES OPERATING REVENUE IN 2024 RMB1.92 BILLION TO RMB2.12 BILLIONSEES NET PROFIT ATTRIBUTABLE TO RANGE FROM RMB58.7 MILLION TO RMB88 MILLION FOR FYFurther company coverage: 603127.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OK0R6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603127"],"gpt_icon":0},{"id":"2505885755","title":"Joinn Laboratories China Sees Net Profit Attributable to Range From RMB58.7 Mln to RMB88 Mln for FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2505885755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505885755?lang=en_us&edition=full_marsco","pubTime":"2025-01-24 21:19","pubTimestamp":1737724779,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nFWN3OK0R6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2493534447","title":"Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2493534447","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493534447?lang=en_us&edition=full_marsco","pubTime":"2024-12-23 19:28","pubTimestamp":1734953302,"startTime":"0","endTime":"0","summary":"Joinn Laboratories agreed to provide certain services to Staidson Biopharmaceuticals group for 2025, a Friday Hong Kong bourse filing said.Under the agreement, the company will provide professional and technical services and a comprehensive range of pharmaceutical research and development services to the Staidson Group.The proposed annual cap for the services agreement is 50 million yuan.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0046","BK1576","603127","BK1141","300204","BK0028","BK0216","06127","BK0239"],"gpt_icon":0},{"id":"2492445199","title":"Joinn Laboratories China Co Ltd - Resolved to Nominate Gu Jingliang as an Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2492445199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492445199?lang=en_us&edition=full_marsco","pubTime":"2024-12-20 21:42","pubTimestamp":1734702168,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0SQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2480021664","title":"Joinn Laboratories' Q3 Profit Slides 58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480021664","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480021664?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 14:42","pubTimestamp":1730443372,"startTime":"0","endTime":"0","summary":"Joinn Laboratories' attributable profit fell 58% year over year to 99.4 million yuan in the third quarter, according to a Wednesday filing with the Hong Kong Exchange.Earnings per share at the pharmacology and toxicology research company decreased 59% year over year to 0.13 yuan.Operating income declined 16% year over year to 485.8 million yuan.Shares fell 1% during Friday's trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["603127","BK1576","06127","BK0216","BK1141"],"gpt_icon":0},{"id":"2479019112","title":"Joinn Laboratories China - Qtrly REV RMB485.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2479019112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479019112?lang=en_us&edition=full_marsco","pubTime":"2024-10-30 20:23","pubTimestamp":1730291004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61K6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["603127","BK0216"],"gpt_icon":0},{"id":"2479420150","title":"Joinn Laboratories China - Resolved to Nominate Xi Luo as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2479420150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479420150?lang=en_us&edition=full_marsco","pubTime":"2024-10-30 20:19","pubTimestamp":1730290747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M61H9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","603127"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.3047},{"period":"3month","weight":-0.0159},{"period":"6month","weight":-0.0838},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0667}],"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"74947万元","compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0437},{"period":"3month","weight":0.0108},{"period":"6month","weight":0.0047},{"period":"1year","weight":0.0659},{"period":"ytd","weight":-0.0224}],"survey":" 北京昭衍新药研究中心股份有限公司的主营业务是从事以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。","serverTime":1745074696352,"listedPrice":12.51,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Joinn Laboratories (China) Co.,Ltd.(603127),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Joinn Laboratories (China) Co.,Ltd.(603127) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Joinn Laboratories (China) Co.,Ltd.,603127,Joinn Laboratories (China) Co.,Ltd.股票,Joinn Laboratories (China) Co.,Ltd.股票老虎,Joinn Laboratories (China) Co.,Ltd.股票老虎国际,Joinn Laboratories (China) Co.,Ltd.行情,Joinn Laboratories (China) Co.,Ltd.股票行情,Joinn Laboratories (China) Co.,Ltd.股价,Joinn Laboratories (China) Co.,Ltd.股市,Joinn Laboratories (China) Co.,Ltd.股票价格,Joinn Laboratories (China) Co.,Ltd.股票交易,Joinn Laboratories (China) Co.,Ltd.股票购买,Joinn Laboratories (China) Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Joinn Laboratories (China) Co.,Ltd.(603127),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Joinn Laboratories (China) Co.,Ltd.(603127) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}